Home LiteratureArticle Details
PMID: 21741965 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2.

European journal of pharmacology ·Vol. 668 ·No. 1-2 ·2011-10-01 ·Pages 299-304

Kashem SW, Subramanian H, Collington SJ, Magotti P, Lambris JD, Ali H

Abstract

Although human mast cells express G protein coupled receptors for the anaphylatoxin C3a, previous studies indicated that C3a causes mast cell degranulation, at least in part, via a C3a receptor-independent mechanism similar to that proposed for polycationic molecules such as compound 48/80. The purpose of the present study was to delineate the receptor specificity of C3a-induced degranulation in human mast cells. We found that C3a, a C3a receptor "superagonist" (E7) and compound 48/80 induced Ca(2+) mobilization and degranulation in a differentiated human mast cell line, LAD2. However, C3a and E7 caused Ca(2+) mobilization in an immature mast cell line, HMC-1 but compound 48/80 did not. We have previously shown that LAD2 cells express MrgX1 and MrgX2 but HMC-1 cells do not. To delineate the receptor specificity for C3a and compound 48/80 further, we generated stable transfectants expressing MrgX1 and MrgX2 in a rodent mast cell line, RBL-2H3 cells. We found that compound 48/80 caused degranulation in RBL-2H3 cells expressing MrgX1 and MrgX2 but C3a did not. By contrast, E7 activated RBL-2H3 cells expressing MrgX2 but not MrgX1. These findings demonstrate that in contrast to previous reports, C3a and compound 48/80 do not use a shared mechanism for mast cell degranulation. It shows that while compound 48/80 utilizes MrgX1 and MrgX2 for mast cell degranulation C3a does not. It further reveals the novel finding that the previously characterized synthetic peptide, C3a receptor "superagonist" E7 activates human mast cells via two mechanisms; one involving the C3a receptor and the other MrgX2.

MeSH Terms
Amino Acid Sequence Cell Degranulation/drug effects Cell Line Complement C3a/agonists,chemistry,metabolism Humans Mast Cells/cytology,drug effects,metabolism Molecular Sequence Data Nerve Tissue Proteins/agonists,genetics,metabolism Peptide Fragments/chemistry,pharmacology Proto-Oncogene Mas Proto-Oncogene Proteins/genetics Receptors, G-Protein-Coupled/agonists,genetics,metabolism Receptors, Neuropeptide/agonists,genetics,metabolism Substrate Specificity p-Methoxy-N-methylphenethylamine/pharmacology
Chemicals
MRGPRX2 protein, human Nerve Tissue Proteins Peptide Fragments Proto-Oncogene Mas Proto-Oncogene Proteins Receptors, G-Protein-Coupled Receptors, Neuropeptide mas-related gene-X1 receptor, human p-Methoxy-N-methylphenethylamine Complement C3a
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Kashem Sakeen W
Department of Pathology, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
Subramanian Hariharan
Collington Sarah J
Magotti Paola
Lambris John D
Ali Hydar
References (30)
30 references, click to expand
  1. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.
    J Immunol. 1990 Sep 15;145(6):1851-8 PMID: 1697312
  2. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons.
    Cell. 2001 Sep 7;106(5):619-32 PMID: 11551509
  3. PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells.
    Mol Pharmacol. 2011 Jun;79(6):1005-13 PMID: 21441599
  4. Novel analogues of the therapeutic complement inhibitor compstatin with significantly improved affinity and potency.
    Mol Immunol. 2011 Jan;48(4):481-9 PMID: 21067811
  5. Designing synthetic superagonists of C3a anaphylatoxin.
    Biochemistry. 1991 Apr 16;30(15):3603-12 PMID: 2015217
  6. Regulation of mast cell activation by complement-derived peptides.
    Immunol Lett. 2004 Mar 29;92(1-2):39-42 PMID: 15081525
  7. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
    J Invest Dermatol. 1994 May;102(5):803-6 PMID: 7513741
  8. Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT.
    J Immunol. 2000 Dec 15;165(12):7215-23 PMID: 11120854
  9. Peptidergic pathway in human skin and rat peritoneal mast cell activation.
    Immunopharmacology. 1994 Jan-Feb;27(1):1-11 PMID: 7515863
  10. Characterization of the Mas-related gene family: structural and functional conservation of human and rhesus MrgX receptors.
    Br J Pharmacol. 2006 Jan;147(1):73-82 PMID: 16284629
  11. Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood.
    Curr Protoc Immunol. 2010 Aug;Chapter 7:Unit 7.37 PMID: 20814942
  12. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI.
    Leuk Res. 2003 Aug;27(8):677-82 PMID: 12801524
  13. Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. Role of multiple G proteins and receptor phosphorylation.
    J Biol Chem. 1994 Oct 7;269(40):24557-63 PMID: 7929127
  14. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
    J Immunol. 1996 Aug 15;157(4):1693-8 PMID: 8759757
  15. Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5.
    J Immunol. 2008 May 1;180(9):6307-16 PMID: 18424754
  16. Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitization.
    J Biol Chem. 1993 Nov 15;268(32):24247-54 PMID: 8226971
  17. Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase.
    Mol Immunol. 2005 Mar;42(5):581-7 PMID: 15607817
  18. Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a.
    Clin Immunol. 2004 Feb;110(2):172-80 PMID: 15003814
  19. Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors.
    Biochem Biophys Res Commun. 2006 Nov 3;349(4):1322-8 PMID: 16979137
  20. Cutting edge: Differential regulation of chemoattractant receptor-induced degranulation and chemokine production by receptor phosphorylation.
    J Immunol. 2001 Oct 1;167(7):3559-63 PMID: 11564766
  21. Proenkephalin A gene products activate a new family of sensory neuron--specific GPCRs.
    Nat Neurosci. 2002 Mar;5(3):201-9 PMID: 11850634
  22. Mast cell activation is characterized by upregulation of a functional anaphylatoxin C5a receptor.
    BMC Immunol. 2008 Jun 17;9:29 PMID: 18559098
  23. A mechanism of action for anaphylatoxin C3a stimulation of mast cells.
    J Immunol. 1992 Apr 15;148(8):2456-61 PMID: 1373170
  24. A protocol for generating high numbers of mature and functional human mast cells from peripheral blood.
    Clin Exp Allergy. 2007 Sep;37(9):1404-14 PMID: 17845422
  25. MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion.
    J Biol Chem. 2003 Nov 7;278(45):44400-4 PMID: 12915402
  26. C3a enhances nerve growth factor-induced NFAT activation and chemokine production in a human mast cell line, HMC-1.
    J Immunol. 2004 Jun 1;172(11):6961-8 PMID: 15153516
  27. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell.
    J Allergy Clin Immunol. 2005 Jun;115(6):1162-8 PMID: 15940129
  28. Conformational analysis of COOH-terminal segments of human C3a. Evidence of ordered conformation in an active 21-residue peptide.
    J Biol Chem. 1984 Jun 25;259(12):7367-70 PMID: 6610676
  29. C3a and C5a stimulate chemotaxis of human mast cells.
    Blood. 1997 Apr 15;89(8):2863-70 PMID: 9108406
  30. Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family.
    Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10043-8 PMID: 12909716
Article Info
Journal
European journal of pharmacology
Abbr.
Eur J Pharmacol
ISSN
1879-0712
Published
2011-10-01
Epub
2011-00-03
Pages
299-304
Language
English
Region
Netherlands
NLM ID
1254354
PMCID
PMC3169012
Subset
IM
Grants
NIAID NIH HHS · P01 AI068730-01A1 · United States
NHLBI NIH HHS · R01 HL085774-02 · United States
NIAID NIH HHS · R56 AI080852-01 · United States
NIAID NIH HHS · AI080852 · United States
NHLBI NIH HHS · R01 HL085774 · United States
NIAID NIH HHS · AI068730 · United States
NIAID NIH HHS · R56 AI080852 · United States
NIAID NIH HHS · P01 AI068730 · United States
NHLBI NIH HHS · HL085774 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]